“…Cryptosporidium hominis is the dominant species in humans in many industrialised countries and in developing countries, whereas, in the Middle East, European countries and New Zealand, C. parvum occurs at similar rates to C. hominis [ 1 ], indicating that zoonotic transmission is more prevalent in countries with intensive farming [ 122 ]. Although largely anthropologically transmitted, there have been numerous reports of C. hominis in animals (including non-human primates, cattle, sheep, goats, horses, donkeys, Bactrian camels, birds, marsupials, a dugong, badger, dingo, foxes, flying fox, rodents, and fish) and experimental infections has been established in calves, lambs, piglets, gerbils, and mice [ 123 , 124 , 125 ]. In human infectivity trials, the 50% infectious dose (ID 50 ) was as low as 10 C. hominis oocysts [ 126 ], however, in animal models, much larger numbers of oocysts were required to achieve infections, suggesting that higher doses are required to cause infection in animals [ 125 ].…”